Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2010 Jul;17(3):264-7.
doi: 10.4103/0974-9233.65500.

Early experience with intravitreal bevacizumab combined with laser treatment for retinopathy of prematurity

Ayesha E Ahmed  1 , Roomasa Channa, Jibran Durrani, Azam Ali, Khabir Ahmad
Affiliations

Early experience with intravitreal bevacizumab combined with laser treatment for retinopathy of prematurity

Ayesha E Ahmed et al. Middle East Afr J Ophthalmol. 2010 Jul.

Abstract

Objective: This study was designed to present our early experience with intravitreal bevacizumab combined with laser treatment for retinopathy of prematurity (ROP) at a single institution over a 13-month-period.

Methods: A retrospective case series of eight children with ROP who received intravitreal bevacizumab combined with laser treatment between June 2007 and July 2008 were reported. A chart review was conducted to evaluate if stability of the ROP lesion had been achieved. Main information collected included data on demographics, gestational age, birth weight, length of stay in neonatal intensive care unit, and stage of ROP.

Results: Fifteen eyes of eight subjects were treated. One eye did not receive any treatment due to complete retinal detachment. The median age at treatment was 8 weeks (range, 6 weeks to 1 year). The most common stage of ROP was 3+. All eyes remained stable at 1 year or later after treatment.

Conclusion: Intravitreal bevacizumab in conjunction with laser treatment had promising results at our institution. We recommend prospective, randomized, controlled clinical trials to compare the effect of laser treatment alone, of bevacizumab treatment alone (at different doses), and of combined bevacizumab and laser treatment.

Keywords: Intravitreal Bevacizumab; Laser treatment; Retinopathy of Prematurity.

PubMed Disclaimer

Conflict of interest statement

Conflict of Interest: None declared.

Similar articles

See all similar articles

Cited by

References

    1. Terry TL. Retrolental Fibroplasia in the Premature Infant: V.Further Studies on Fibroplastic Overgrowth of the Persistent Tunica Vasculosa Lentis. Trans Am Ophthalmol Soc. 1944;42:383–96. - PMC - PubMed
    1. Chen J, Smith LE. Retinopathy of prematurity. Angiogenesis. 2007;10:133–40. - PubMed
    1. Patz A. Clinical and experimental studies on retinal neovascularization.XXXIX Edward Jackson Memorial Lecture. Am J Ophthalmol. 1982;94:715–43. - PubMed
    1. Senger DR, Galli SJ, Dvorak AM, Perruzzi CA, Harvey VS, Dvorak HF. Tumor cells secrete a vascular permeability factor that promotes accumulation of ascites fluid. Science. 1983;219:983–5. - PubMed
    1. Leung DW, Cachianes G, Kuang WJ, Goeddel DV, Ferrara N. Vascular endothelial growth factor is a secreted angiogenic mitogen. Science. 1989;246:1306–9. - PubMed